Carl R Merril
Inventor
Stats
- 26 US patents issued
- 41 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 26 US Patents Issued
- 41 US Applications Filed
- 552 Total Citation Count
- Apr 23, 2020 Most Recent Filing
- Jan 18, 1982 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1
2 1 1 1 1 5 1 1 4 2 3 5 1 1 | 1982
1984 1986 1987 1988 1991 1992 1993 1994 1995 1996 2001 2003 2004 2005 |
Panacea Pharmaceuticals, Inc. | 3
1 1 | 2001
2013 2016 |
Exponential Biotherapies, Inc. | 2
2 2 1 | 1995
1996 2001 2003 |
PANACEA PHARMACEUTICALS | 3
| 2013
|
VIRXSYS CORPORATION | 2
1 | 2003
2008 |
Monoclonetics International, Inc. | 1
1 1 1 | 1987
1992 1994 1995 |
THE UNITED STATES OF AMERICA | 1
| 1992
|
Inventor Addresses
Address | Duration |
---|---|
2 Winder Ct., Rockville, MD 20850 | Jul 04, 95 - Jul 04, 95 |
Bethesda, MD | Oct 17, 02 - Jul 15, 08 |
Bethesda, MD, US | Jul 08, 04 - Aug 06, 20 |
ROCKVILLE, MD | Feb 06, 03 - Feb 06, 03 |
Rockville, MD | Sep 20, 83 - Feb 19, 08 |
Rockville, MD, US | Nov 20, 03 - Nov 20, 03 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 19 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 7 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2020/0246,443 | 2020 | THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE) | 0 |
10702591 | 2020 | Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase | 0 |
2018/0092,969 | 2018 | Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-Beta-Hydroxylase | 0 |
9744223 | 2017 | Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase) | 1 |
2017/0072,034 | 2017 | THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE) | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.